Nancy Guillen, Ph.D.Associate Director at Johnson and Johnson Innovative MedicinesSpeaker
Agenda Sessions
Integration of Experimental Execution, Statistics and Multivariate Data Analysis to Optimize Process Performance and Product Quality in the Production of Multispecific Antibody Therapies in CHO Cells
, 2:30pmView Session

